DISSOLUTION TESTING OF HYDROPHOBIC ACTIVE PHARMACEUTICAL INGREDIENTS SUCH AS AVERMECTINS WITH OR WITHOUT PYRANTEL

摘要

This disclosure describes the results of the studies conducted to develop a dissolution method to monitor release profiles of hydrophobic active pharmaceutical ingredients such as ivermectin with or without pyrantel pamoate from a drug product made of complex matrix that includes, but is not limited to beef, tallow, corn cob and soy protein.